NUMINUS WELLNESS INC (NUMI.CA) Fundamental Analysis & Valuation
TSX:NUMI • CA67054W1032
Current stock price
0.05 CAD
+0.02 (+42.86%)
Last:
This NUMI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NUMI.CA Profitability Analysis
1.1 Basic Checks
- NUMI had negative earnings in the past year.
- NUMI had a negative operating cash flow in the past year.
- In the past 5 years NUMI always reported negative net income.
- NUMI had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- NUMI has a Return On Assets of -213.24%. This is amonst the worse of the industry: NUMI underperforms 90.91% of its industry peers.
- The Return On Equity of NUMI (-644.74%) is worse than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -213.24% | ||
| ROE | -644.74% | ||
| ROIC | N/A |
ROA(3y)-79.64%
ROA(5y)-255.28%
ROE(3y)-118.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of NUMI (32.02%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of NUMI has grown nicely.
- NUMI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y52.27%
GM growth 5YN/A
2. NUMI.CA Health Analysis
2.1 Basic Checks
- NUMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for NUMI has been increased compared to 1 year ago.
- The debt/assets ratio for NUMI is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -13.73, we must say that NUMI is in the distress zone and has some risk of bankruptcy.
- NUMI has a worse Altman-Z score (-13.73) than 81.82% of its industry peers.
- A Debt/Equity ratio of 0.95 indicates that NUMI is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.95, NUMI is doing worse than 78.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -13.73 |
ROIC/WACCN/A
WACC8.99%
2.3 Liquidity
- A Current Ratio of 1.40 indicates that NUMI should not have too much problems paying its short term obligations.
- The Current ratio of NUMI (1.40) is comparable to the rest of the industry.
- A Quick Ratio of 1.40 indicates that NUMI should not have too much problems paying its short term obligations.
- NUMI has a better Quick ratio (1.40) than 60.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 1.4 |
3. NUMI.CA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 37.67% over the past year.
- Looking at the last year, NUMI shows a very strong growth in Revenue. The Revenue has grown by 22.69%.
- Measured over the past years, NUMI shows a very strong growth in Revenue. The Revenue has been growing by 197.54% on average per year.
EPS 1Y (TTM)37.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.87%
Revenue 1Y (TTM)22.69%
Revenue growth 3Y197.54%
Revenue growth 5YN/A
Sales Q2Q%-27.88%
3.2 Future
- The Earnings Per Share is expected to grow by 29.53% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 22.63% on average over the next years. This is a very strong growth
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y25.99%
EPS Next 5Y29.53%
Revenue Next Year-18.04%
Revenue Next 2Y-0.45%
Revenue Next 3Y11.96%
Revenue Next 5Y22.63%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. NUMI.CA Valuation Analysis
4.1 Price/Earnings Ratio
- NUMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NUMI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- NUMI's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.44%
EPS Next 3Y25.99%
5. NUMI.CA Dividend Analysis
5.1 Amount
- NUMI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NUMI.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:NUMI (1/29/2025, 7:00:00 PM)
0.05
+0.02 (+42.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength33.59
Industry Growth45.52
Earnings (Last)01-13 2025-01-13
Earnings (Next)N/A N/A
Inst Owners2.66%
Inst Owner ChangeN/A
Ins Owners3.55%
Ins Owner ChangeN/A
Market Cap16.12M
Revenue(TTM)26.05M
Net Income(TTM)-29.86M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.62 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.48 | ||
| P/tB | 3.48 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.08
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -213.24% | ||
| ROE | -644.74% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.02% | ||
| FCFM | N/A |
ROA(3y)-79.64%
ROA(5y)-255.28%
ROE(3y)-118.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y52.27%
GM growth 5YN/A
F-Score2
Asset Turnover1.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.51% | ||
| Cap/Sales | 0.14% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | -13.73 |
F-Score2
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)61.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)21.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.87%
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y25.99%
EPS Next 5Y29.53%
Revenue 1Y (TTM)22.69%
Revenue growth 3Y197.54%
Revenue growth 5YN/A
Sales Q2Q%-27.88%
Revenue Next Year-18.04%
Revenue Next 2Y-0.45%
Revenue Next 3Y11.96%
Revenue Next 5Y22.63%
EBIT growth 1Y24.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.26%
OCF growth 3YN/A
OCF growth 5YN/A
NUMINUS WELLNESS INC / NUMI.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NUMINUS WELLNESS INC (NUMI.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to NUMI.CA.
What is the valuation status of NUMINUS WELLNESS INC (NUMI.CA) stock?
ChartMill assigns a valuation rating of 1 / 10 to NUMINUS WELLNESS INC (NUMI.CA). This can be considered as Overvalued.
What is the profitability of NUMI stock?
NUMINUS WELLNESS INC (NUMI.CA) has a profitability rating of 1 / 10.
How financially healthy is NUMINUS WELLNESS INC?
The financial health rating of NUMINUS WELLNESS INC (NUMI.CA) is 2 / 10.